Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
383 | 16378 | 32.5 | 73% |
Classes in level above (level 3) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
249 | 42303 | VITAMIN D//HYPERPARATHYROIDISM//SECONDARY HYPERPARATHYROIDISM |
Classes in level below (level 1) |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | PRIMARY HYPERPARATHYROIDISM | Author keyword | 1072 | 77% | 4% | 725 |
2 | HYPERPARATHYROIDISM | Author keyword | 786 | 53% | 6% | 1036 |
3 | SECONDARY HYPERPARATHYROIDISM | Author keyword | 582 | 60% | 4% | 633 |
4 | PARATHYROIDECTOMY | Author keyword | 541 | 68% | 3% | 472 |
5 | CALCIUM SENSING RECEPTOR | Author keyword | 493 | 72% | 2% | 385 |
6 | PARATHYROID ADENOMA | Author keyword | 393 | 74% | 2% | 289 |
7 | PARATHYROID CARCINOMA | Author keyword | 321 | 86% | 1% | 166 |
8 | HYPERCALCEMIA | Author keyword | 287 | 39% | 4% | 577 |
9 | PARATHYROID HORMONE RELATED PROTEIN | Author keyword | 279 | 66% | 2% | 257 |
10 | PARATHYROID HORMONE | Author keyword | 261 | 27% | 5% | 833 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | PRIMARY HYPERPARATHYROIDISM | 1072 | 77% | 4% | 725 | Search PRIMARY+HYPERPARATHYROIDISM | Search PRIMARY+HYPERPARATHYROIDISM |
2 | HYPERPARATHYROIDISM | 786 | 53% | 6% | 1036 | Search HYPERPARATHYROIDISM | Search HYPERPARATHYROIDISM |
3 | SECONDARY HYPERPARATHYROIDISM | 582 | 60% | 4% | 633 | Search SECONDARY+HYPERPARATHYROIDISM | Search SECONDARY+HYPERPARATHYROIDISM |
4 | PARATHYROIDECTOMY | 541 | 68% | 3% | 472 | Search PARATHYROIDECTOMY | Search PARATHYROIDECTOMY |
5 | CALCIUM SENSING RECEPTOR | 493 | 72% | 2% | 385 | Search CALCIUM+SENSING+RECEPTOR | Search CALCIUM+SENSING+RECEPTOR |
6 | PARATHYROID ADENOMA | 393 | 74% | 2% | 289 | Search PARATHYROID+ADENOMA | Search PARATHYROID+ADENOMA |
7 | PARATHYROID CARCINOMA | 321 | 86% | 1% | 166 | Search PARATHYROID+CARCINOMA | Search PARATHYROID+CARCINOMA |
8 | HYPERCALCEMIA | 287 | 39% | 4% | 577 | Search HYPERCALCEMIA | Search HYPERCALCEMIA |
9 | PARATHYROID HORMONE RELATED PROTEIN | 279 | 66% | 2% | 257 | Search PARATHYROID+HORMONE+RELATED+PROTEIN | Search PARATHYROID+HORMONE+RELATED+PROTEIN |
10 | PARATHYROID HORMONE | 261 | 27% | 5% | 833 | Search PARATHYROID+HORMONE | Search PARATHYROID+HORMONE |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | PRIMARY HYPERPARATHYROIDISM | 904 | 52% | 7% | 1223 |
2 | ASYMPTOMATIC PRIMARY HYPERPARATHYROIDISM | 888 | 87% | 3% | 433 |
3 | MINIMALLY INVASIVE PARATHYROIDECTOMY | 805 | 90% | 2% | 350 |
4 | SECONDARY HYPERPARATHYROIDISM | 762 | 45% | 8% | 1280 |
5 | HUMORAL HYPERCALCEMIA | 736 | 75% | 3% | 529 |
6 | CA2 SENSING RECEPTOR | 615 | 75% | 3% | 449 |
7 | NEONATAL SEVERE HYPERPARATHYROIDISM | 579 | 87% | 2% | 287 |
8 | FAMILIAL HYPOCALCIURIC HYPERCALCEMIA | 525 | 80% | 2% | 328 |
9 | SPORADIC PRIMARY HYPERPARATHYROIDISM | 512 | 96% | 1% | 161 |
10 | EXTRACELLULAR CA2 SENSING RECEPTOR | 492 | 80% | 2% | 304 |
Journals |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | THERAPEUTIC APHERESIS AND DIALYSIS | 13 | 11% | 1% | 112 |
2 | ITALIAN JOURNAL OF MINERAL & ELECTROLYTE METABOLISM | 5 | 20% | 0% | 22 |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Genetic mutations in sporadic pituitary adenomas-what to screen for? | 2015 | 4 | 124 | 65% |
Definition, evaluation, and classification of renal osteodystrophy: A position statement from kidney disease: Improving global outcomes (KDIGO) | 2006 | 593 | 29 | 59% |
Serum Levels of Phosphorus, Parathyroid Hormone, and Calcium and Risks of Death and Cardiovascular Disease in Individuals With Chronic Kidney Disease A Systematic Review and Meta-analysis | 2011 | 175 | 66 | 52% |
Hyperparathyroidism | 2009 | 204 | 136 | 74% |
Drug Therapy: Oral Phosphate Binders in Patients with Kidney Failure. | 2010 | 118 | 89 | 82% |
Extracellular calcium sensing and extracellular calcium signaling | 2001 | 745 | 404 | 54% |
Multiple endocrine neoplaslia type 1 (MEN 1): Analysis of 1336 mutations reported in the first decade following identification of the gene | 2008 | 165 | 111 | 86% |
Multiple endocrine neoplasia type 1 (MEN1) and type 4 (MEN4) | 2014 | 11 | 78 | 81% |
The Calcium-Sensing Receptor: A Molecular Perspective | 2011 | 56 | 228 | 87% |
Secondary Hyperparathyroidism: Pathogenesis, Disease Progression, and Therapeutic Options | 2011 | 67 | 72 | 68% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | SECT ENDOCRINE SURG | 46 | 34% | 0.7% | 113 |
2 | ENDOCRINE SURG | 46 | 19% | 1.3% | 219 |
3 | CALCIUM | 36 | 38% | 0.5% | 75 |
4 | METAB DIS BRANCH | 36 | 31% | 0.6% | 97 |
5 | MOL PATHOPHYSIOL SECT | 33 | 100% | 0.1% | 13 |
6 | ENDOCRINE HYPERTENS | 26 | 29% | 0.5% | 77 |
7 | ENDOCRINE SURG UNIT | 26 | 24% | 0.6% | 93 |
8 | NEPHROL BONE MINERAL METAB | 22 | 42% | 0.2% | 39 |
9 | SECT FUNDAMENTAL NEUROSCI | 17 | 68% | 0.1% | 15 |
10 | BLOOD PURIFICAT THER Y | 14 | 47% | 0.1% | 22 |
Related classes at same level (level 2) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000017634 | VASCULAR CALCIFICATION//FGF 23//CALCIPHYLAXIS |
2 | 0.0000011912 | THYROIDECTOMY//THYROID SURGERY//ENDOSCOPIC THYROIDECTOMY |
3 | 0.0000009728 | VITAMIN D//25 HYDROXYVITAMIN D//VITAMIN D DEFICIENCY |
4 | 0.0000007601 | BISPHOSPHONATES//ZOLEDRONIC ACID//BISPHOSPHONATE |
5 | 0.0000006737 | OSTEOPOROSIS//OSTEOPOROSIS INTERNATIONAL//BONE MINERAL DENSITY |
6 | 0.0000006677 | VELOCARDIOFACIAL SYNDROME//DIGEORGE SYNDROME//PSEUDOHYPOPARATHYROIDISM |
7 | 0.0000005556 | MORINGA OLEIFERA//AL 13//POLYALUMINUM CHLORIDE |
8 | 0.0000005133 | NEUROENDOCRINE TUMORS//CARCINOID//GASTRINOMA |
9 | 0.0000004875 | HYPERADRENOCORTICISM//HYPOADRENOCORTICISM//FELINE HYPERTHYROIDISM |
10 | 0.0000004463 | HEMODIALYSIS//BLOOD PURIFICATION//HAEMODIALYSIS |